COGT
Price
$37.79
Change
+$2.51 (+7.11%)
Updated
Jan 14 closing price
Capitalization
5.8B
61 days until earnings call
Intraday BUY SELL Signals
IPHA
Price
$1.75
Change
-$0.06 (-3.31%)
Updated
Jan 14 closing price
Capitalization
165.59M
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs IPHA

Header iconCOGT vs IPHA Comparison
Open Charts COGT vs IPHABanner chart's image
Cogent Biosciences
Price$37.79
Change+$2.51 (+7.11%)
Volume$1.93M
Capitalization5.8B
Innate Pharma SA
Price$1.75
Change-$0.06 (-3.31%)
Volume$34.65K
Capitalization165.59M
COGT vs IPHA Comparison Chart in %
COGT
Daily Signal:
Gain/Loss:
IPHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COGT vs. IPHA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and IPHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (COGT: $37.79 vs. IPHA: $1.75)
Brand notoriety: COGT and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 55% vs. IPHA: 13%
Market capitalization -- COGT: $5.8B vs. IPHA: $165.59M
COGT [@Biotechnology] is valued at $5.8B. IPHA’s [@Biotechnology] market capitalization is $165.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileIPHA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • IPHA’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while IPHA’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 3 bearish.
  • IPHA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +4.19% price change this week, while IPHA (@Biotechnology) price change was -0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

COGT is expected to report earnings on Mar 17, 2026.

IPHA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($5.8B) has a higher market cap than IPHA($166M). COGT YTD gains are higher at: 6.391 vs. IPHA (0.171).
COGTIPHACOGT / IPHA
Capitalization5.8B166M3,495%
EBITDA-308.13MN/A-
Gain YTD6.3910.1713,728%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash391MN/A-
Total Debt60.6MN/A-
FUNDAMENTALS RATINGS
COGT vs IPHA: Fundamental Ratings
COGT
IPHA
OUTLOOK RATING
1..100
614
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
24100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3561
P/E GROWTH RATING
1..100
10035
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPHA's Valuation (77) in the null industry is in the same range as COGT (81) in the Miscellaneous industry. This means that IPHA’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (24) in the Miscellaneous industry is significantly better than the same rating for IPHA (100) in the null industry. This means that COGT’s stock grew significantly faster than IPHA’s over the last 12 months.

IPHA's SMR Rating (98) in the null industry is in the same range as COGT (99) in the Miscellaneous industry. This means that IPHA’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (35) in the Miscellaneous industry is in the same range as IPHA (61) in the null industry. This means that COGT’s stock grew similarly to IPHA’s over the last 12 months.

IPHA's P/E Growth Rating (35) in the null industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that IPHA’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTIPHA
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
IPHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARBTF0.090.01
+19.09%
Argo Gold Inc
CGEMY34.360.22
+0.64%
Capgemini SE
AHEXF26.35N/A
N/A
Adecco Group AG
JAXAF0.04N/A
N/A
VINYL GROUP LTD.
EXMRF11.60N/A
N/A
Exmar S.A.

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+7.11%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
47%
Loosely correlated
+8.59%
GLTO - COGT
44%
Loosely correlated
+7.25%
REPL - COGT
42%
Loosely correlated
-4.10%
CYTOF - COGT
40%
Loosely correlated
-16.39%
More

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-3.15%
MDGL - IPHA
43%
Loosely correlated
+2.29%
APLM - IPHA
36%
Loosely correlated
-4.30%
SLNO - IPHA
34%
Loosely correlated
+2.29%
COGT - IPHA
32%
Poorly correlated
+7.11%
TNXP - IPHA
30%
Poorly correlated
+8.13%
More